Application Nr Approved Date Route Status External Links
ANDA209623 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Teriflunomide Tablet Is Indicated For The Treatment Of Patients With Relapsing Forms Of Multiple Sclerosis. Teriflunomideis A Pyrimidine Synthesis Inhibitor Indicated For The Treatment Of Patients With Relapsing Forms Of Multiple Sclerosis ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Teriflunomide TERIFLUNOMIDE ZINC13512456

Comments